No association between dopaminergic polymorphisms and response to treatment of binge-eating disorder

Brandon A. Heidinger; Jameason D. Cameron; Regis Vaillancourt; Michael De Lisio; Matthew Ngu; Giorgio A. Tasca; Livia Chyurlia; Éric Doucet; Steve Doucette; Ana Maria Obregón Rivas; Gary S. Goldfield

doi:10.1016/j.gene.2021.145538

No association between dopaminergic polymorphisms and response to treatment of binge-eating disorder

Brandon A. Heidinger, Jameason D. Cameron, Regis Vaillancourt, Michael De Lisio, Matthew Ngu, Giorgio A. Tasca, Livia Chyurlia, Éric Doucet, Steve Doucette, Ana Maria Obregón Rivas, Gary S. Goldfield

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Original language	English
Article number	145538
Journal	Gene
Volume	781
DOIs	https://doi.org/10.1016/j.gene.2021.145538
Publication status	Published - May 20 2021
Externally published	Yes

ASJC Scopus Subject Areas

Genetics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.gene.2021.145538

Cite this

@article{d052fefe183f4a3691e957ef83d385b5,

title = "No association between dopaminergic polymorphisms and response to treatment of binge-eating disorder",

author = "Heidinger, {Brandon A.} and Cameron, {Jameason D.} and Regis Vaillancourt and {De Lisio}, Michael and Matthew Ngu and Tasca, {Giorgio A.} and Livia Chyurlia and {\'E}ric Doucet and Steve Doucette and {Maria Obreg{\'o}n Rivas}, Ana and Goldfield, {Gary S.}",

note = "Funding Information: This work was supported by the Canadian Institute of Health Research (CIHR) MOP – [grant number 82752]; the Ontario Mental Health Foundation (OMHF) Type A Grant; and the Shire Investigator-Initiated Grant. Funding Information: This Investigator-Initiated Research (IIR-CAN-001751) was supported by Shire International GmbH (Switzerland), a member of the Takeda group of companies. The primary analysis of the data in this study was supported by an operating grant from the Institute of Gender and Health of the Canadian Institutes of Health Research awarded to Dr. Tasca. Publisher Copyright: {\textcopyright} 2021 Elsevier B.V.",

year = "2021",

month = may,

day = "20",

doi = "10.1016/j.gene.2021.145538",

language = "English",

volume = "781",

journal = "Gene",

issn = "0378-1119",

publisher = "Elsevier",

}

TY - JOUR

T1 - No association between dopaminergic polymorphisms and response to treatment of binge-eating disorder

AU - Heidinger, Brandon A.

AU - Cameron, Jameason D.

AU - Vaillancourt, Regis

AU - De Lisio, Michael

AU - Ngu, Matthew

AU - Tasca, Giorgio A.

AU - Chyurlia, Livia

AU - Doucet, Éric

AU - Doucette, Steve

AU - Maria Obregón Rivas, Ana

AU - Goldfield, Gary S.

N1 - Funding Information: This work was supported by the Canadian Institute of Health Research (CIHR) MOP – [grant number 82752]; the Ontario Mental Health Foundation (OMHF) Type A Grant; and the Shire Investigator-Initiated Grant. Funding Information: This Investigator-Initiated Research (IIR-CAN-001751) was supported by Shire International GmbH (Switzerland), a member of the Takeda group of companies. The primary analysis of the data in this study was supported by an operating grant from the Institute of Gender and Health of the Canadian Institutes of Health Research awarded to Dr. Tasca. Publisher Copyright: © 2021 Elsevier B.V.

PY - 2021/5/20

Y1 - 2021/5/20

UR - http://www.scopus.com/inward/record.url?scp=85102064022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85102064022&partnerID=8YFLogxK

U2 - 10.1016/j.gene.2021.145538

DO - 10.1016/j.gene.2021.145538

M3 - Article

C2 - 33631245

AN - SCOPUS:85102064022

SN - 0378-1119

VL - 781

JO - Gene

JF - Gene

M1 - 145538

ER -

No association between dopaminergic polymorphisms and response to treatment of binge-eating disorder

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this